[ad_1]
© Reuters. FILE PHOTO: Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken November 27, 2021. REUTERS/Dado Ruvic/Illustration
NEW YORK (Reuters) – Vaccine maker Moderna (NASDAQ:) Inc’s chief commercial officer (CCO) said on Thursday that the size of the future COVID-19 vaccine market in the United States could be in the range of $5.2 billion to $12.9 billion, depending on the price of shots and who is eligible to receive them.
Globally, the company said the size of the high-risk population that would be eligible for the shots is around 340 million people, Moderna CCO Arpa Garay said, speaking at the company’ annual reseacrh and development event.
[ad_2]
Image and article originally from www.investing.com. Read the original article here.